Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors
Authors:
Open Access
- 26 November 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1429483
Abstract
Immunotherapy has become a global focus in cancer treatment and research, with promising results from targeting immune checkpoints in tumors like non-small cell lung cancer, colon cancer, and melanoma. However, resistance to immune checkpoint inhibitors (ICIs) remains a significant challenge. Traditional Chinese medicine (TCM), known for its low toxicity and minimal side effects, shows promise in enhancing cancer treatment when combined with modern therapies. This study reviews recent research on ICIs resistance mechanisms and highlights TCM’s potential in overcoming this resistance, aiming to improve ICIs efficacy while minimizing toxicity.Keywords
This publication has 95 references indexed in Scilit:
- Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathwayJournal of Cancer Research and Clinical Oncology, 2024
- Immunologic tumor microenvironment modulators for turning cold tumors hotCancer Communications, 2024
- MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomesBiomaterials, 2024
- Exploring the mechanism and key active components of Gegen Qinlian decoction combined with XELOX in the treatment of ulcerative colitis-associated colorectal cancer based on network pharmacology and multi-omics analysisArabian Journal of Chemistry, 2024
- Global pannexin 1 deletion increases tumor‐infiltrating lymphocytes in the BRAF/Pten mouse melanoma modelMolecular Oncology, 2024
- WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responsesClinical and Experimental Medicine, 2024
- Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBCCancer Immunology, Immunotherapy, 2021
- Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinomaCancer Immunology, Immunotherapy, 2019
- Galangin inhibits the cell progression and induces cell apoptosis through activating PTEN and Caspase-3 pathways in retinoblastomaBiomedicine & Pharmacotherapy, 2018
- High coexpression of CCL2 and CX3CL1 is gender‐specifically associated with good prognosis in soft tissue sarcoma patientsInternational Journal of Cancer, 2014